Abstract: Method and devices for dynamically preventing printing errors caused by a media deformation are disclosed. In one example, a pen to print media space (PPS) distance is measured. A media deformation is identified in response to measuring the PPS distance. A corrective function is identified in response to identifying the media deformation. The corrective function identified is then performed. The proposed method provides for consistent quality across a print.

Abstract: Disclosed herein is a method of sublimation printing, a heating system for sublimation printing and a printing device. The method of sublimation printing comprises generating an air flow through a print medium on which a printing substance is deposited and heating the air flow to a temperature at or above a sublimation temperature of the printing substance.

Abstract: The invention provides a method for the treatment of Ph+ leukemia in a patient comprising administering to the patient (i) a BCR-ABL tyrosine kinase inhibitor, and (ii) an agent which selectively binds to a cell surface receptor expressed on Ph+ leukemic stem cells. The invention further provides for the use of (i) and (ii) in, or in the manufacture of a medicament for, the treatment of Ph+ leukemia in a patient; and a composition for the treatment of Ph+ leukemia in a patient comprising (i) and (ii); and kits comprising (i) and (ii). In some embodiments, the tyrosine kinase inhibitor is or is not imatinib; or is selected from the group consisting of dasatinib, nilotinib, bosutinib, axitinib, cediranib, crizotinib, damnacanthal, gefitinib, lapatinib, lestaurtinib, neratinib, semaxanib, sunitinib, toceranib, tyrphostins, vandetanib, vatalanib, INNO-406, AP24534, XL228, PHA-739358, MK-0457, SGX393 and DC2036; or is selected from the group consisting of dasatinib and nilotinib.

Abstract: Methods of treating or slowing the growth of a lesion associated with geographic atrophy and methods of evaluating a drug or agent for use in treating, reducing the progression of or slowing the growth of a lesion associated with geographic atrophy.

Abstract: A system and method is provided for controlling operating of an engine having a turbocharger with a compressor and an exhaust turbine, wherein the compressor is configured to provide a boost pressure and operate stably in a stable operating range between a surge line and a choke line of a compressor map. A controller is configured to control an actuator to cause an operating point of the compressor to move along a predetermined path within a corridor along a safety zone in the compressor map. The safety zone extends along the surge line. The safety zone is selected to provide a distance between the surge line and the corridor that minimizes a reduction of the boost pressure such that a sufficient boost pressure is available after the network fault.

Abstract: The invention concerns a toy system comprising a toy figurine and a spinner body, the spinner body having an elongate axis; a sidewall; and a bottom wall, wherein said sidewall of the spinner body comprises a top rim; an outside surface; and an inside surface, wherein said bottom wall comprises an outside bottom surface; and an inside bottom surface, wherein the inner bottom surface comprises first connection means for releasably connecting second connection means of said toy figurine to the toy spinning top, wherein said sidewall has a height from said inner bottom surface of said top rim, and wherein the height from said inner bottom surface to said top rim is equal a height of the toy figurine from second connection means formed at one end of legs to a shoulder portion of a body formed between the legs and a head resting on said shoulder portion.

Abstract: Systems, methods, devices, and techniques for estimating an ejection-fraction characteristic of a mammal. An electrocardiogram (ECG) procedure is performed on a mammal, and a computer system obtains ECG data that describes results of the ECG over a period of time. The system provides a predictive input that is based on the ECG data to an ejection-fraction predictive model, such as a neural network or other machine-learning model. In response, the ejection-fraction predictive model processes the input to generate an estimated ejection-fraction characteristic of the mammal. The system outputs the estimated ejection-fraction characteristic of the mammal for presentation to a user.

Abstract: A soft robot hand includes a palm, a first fabric-reinforced textile actuator coupled to the palm, and a second fabric-reinforced textile actuator coupled to the palm. The first actuator is moveable relative to the palm between a collapsed position and an inflated position to approximate a joint in a first human finger. The second actuator is spaced apart from the first actuator. The second actuator is moveable relative to the palm between a collapsed position and an inflated position to approximate a joint in a second human finger.

Abstract: Internal combustion engine (10) with: at least one turbocharger which has a compressor (1) and an exhaust turbine (2), and which can be stably operated in a stable operating range of a compressor map of the at least one compressor (1), which stable operating range is limited by a surge line (P) on the one hand, and by a choke line (S) on the other hand at least one actuator for setting an operating point (4) of the at least one compressor (1) in the compressor map a measuring device (5) for measuring at least two operating parameters of the turbocharger, by means of which a position of an operating point (4) of the at least one compressor (1) is determinable in the compressor map a closed loop or open loop control device (6) which is connected to the measuring device (5), and is designed to activate the at least one actuator whereby the closed loop or open loop control device (6) is designed in a way to regulate or control the at least one actuator in such a way that reaching the surge line (P) by the opera

Abstract: The invention provides a method for the treatment of Ph+ leukemia in a patient comprising administering to the patient (i) a BCR-ABL tyrosine kinase inhibitor, and (ii) an agent which selectively binds to a cell surface receptor expressed on Ph+ leukemic stem cells. The invention further provides for the use of (i) and (ii) in, or in the manufacture of a medicament for, the treatment of Ph+ leukemia in a patient; and a composition for the treatment of Ph+ leukemia in a patient comprising (i) and (ii); and kits comprising (i) and (ii). In some embodiments, the tyrosine kinase inhibitor is or is not imatinib; or is selected from the group consisting of dasatinib, nilotinib, bosutinib, axitinib, cediranib, crizotinib, damnacanthal, gefitinib, lapatinib, lestaurtinib, neratinib, semaxanib, sunitinib, toceranib, tyrphostins, vandetanib, vatalanib, INNO-406, AP24534, XL228, PHA-739358, MK-0457, SGX393 and DC2036; or is selected from the group consisting of dasatinib and nilotinib.

Abstract: Examples of systems and methods for improved hand tracking of a user in a mixed reality environment are disclosed. The systems and methods may be configured to estimate the hand pose and shape of a user's hands for applications such as animating a hand on a user's avatar. Data from multiple sources, such as a totem internal measurement unit (“IMU”), external totem location tracking, vision cameras, and depth sensors, may be manipulated using a set of rules that are based on historical data, ergonomics data, and motion data.

Abstract: A printing system may comprise a page wide array printhead a capping station, and a number of modular caps comprising a housing to cover a nozzle array of a printhead and a cap coupler coupled to the housing to couple the cap to the nozzle array in which the modular caps are adapted to be coupled to and removed from the nozzle array of the printhead and stored in the capping station.

Abstract: A genset including at least one generator for generating electrical energy, which can be driven by a drive device is provided. Also provided is a detection device for detection of the presence of a grid fault in at least one phase of the power grid, a device for determining an operating state of the generator immediately before or upon detection of a grid fault, and a regulating device, to which the signals of the detection device and the device for determining an operating state of the generator can be fed. The regulating device is designed upon detection of a grid fault to reduce the power of the drive device in dependence of that operating state of the generator, which has been determined immediately before or upon detection of the grid fault.

Abstract: A method of operating an arrangement includes using a rotating drive machine, wherein a value characteristic of a change of a power output of the arrangement is provided by measuring at least one parameter and/or calculation. The rotating drive machine is open and/or closed loop controlled depending on the value characteristic of the change of the power output of the arrangement and/or a load of the rotating drive machine is changed depending on the value characteristic of the change of the power output of the arrangement, such that the change of the power output of the arrangement is substantially compensated.

Abstract: The invention relates to an optimized folding display, comprising two facing main side panels (1, 2), a traverse assembly (3) formed by narrow and elongated rectangular boards of semi-flexible sheet material, and fixing means (11, 12, 13, 14) for keeping the traverses fixed to the outer surface of the corresponding side panel (1, 2). The traverses (3) have their planes separated a given distance, so they form an articulated rhombus which can diagonally be closed from an expanded position into a folded position. Furthermore, the display has at least one shelf element (15) located between the two side panels (1, 2) and resting flat on the traverses (3) located at a similar height, forming a shelving assembly.

Abstract: The present invention provides a method of screening a mammal for the onset or predisposition to the onset of a neuropsychiatric disorder. More particularly, the present invention provides a method of screening a mammal for the onset or predisposition to the onset of schizophrenia by screening for a decrease in the functional level of protein 14-3-3?. In a related aspect, the present invention also provides a means of monitoring a patient diagnosed with a neuropsychiatric disorder, such as schizophrenia, by screening for changes to functional levels of protein 14-3-3?. This may be useful, for example, in the context of evaluating the effectiveness of a prophylactic or therapeutic treatment regime or otherwise monitoring the impact of physiological or metabolic changes which may occur in a patient.

Abstract: A replacement heart valve device including a stent member that is to be compressible and expandable, and a dry valve directly sutured to the stent member. The dry valve includes two to four leaflets made of a treated pericardium tissue that has been gas sterilized.

Abstract: The present invention provides a method of screening a mammal for the onset or predisposition to the onset of a neuropsychiatric disorder. More particularly, the present invention provides a method of screening a mammal for the onset or predisposition to the onset of schizophrenia by screening for a decrease in the functional level of protein 1 4-3-3?. In a related aspect, the present invention also provides a means of monitoring a patient diagnosed with a neuropsychiatric disorder, such as schizophrenia, by screening for changes to functional levels of protein 14-3-3 ?. This may be useful, for example, in the context of evaluating the effectiveness of a prophylactic or therapeutic treatment regime or otherwise monitoring the impact of physiological or metabolic changes which may occur in a patient.

Abstract: A method of making a replacement heart valve device whereby a fragment of biocompatible tissue material is treated and soaked in one or more alcohol solutions and a solution of glutaraldehyde. The dried biocompatible tissue material is folded and rehydrated in such a way that forms a two- or three-leaflet/cusp valve without affixing of separate cusps or leaflets or cutting slits into the biocompatible tissue material to form the cusps or leaflets. After the biocompatible tissue material is folded, it is affixed at one or more points on the outer surface to the inner cavity or a stent.